AJ
Ajanta Pharma
AJANTPHARM.NS·NSEMumbai INFounded 19736,000 employees
Mid CappharmaPublicDermatologyOphthalmology
Platform: Branded Derm
Market Cap
$4B
All Drugs
3
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (AJANTPHARM.NS)
Loading AJANTPHARM.NS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisofotisoran | AJA-8014 | NDA/BLA | 1 | FcRn | MGALS | ||
| AJA-5085 | AJA-5085 | Preclinical | 1 | TIGIT | Ewing SarcomaEndometrial Ca | ||
| Tezetinib | AJA-1290 | Phase 1 | 2 | KIF18A | Gastric Ca |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Ajanta Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)